Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: genetics

Nanomedicine discovery uses salt to overcome major obstacle in gene therapy

Researchers at the University of Houston’s College of Pharmacy have discovered an unexpectedly simple strategy to improve the performance of mRNA vaccines and gene therapeutics: adding salt. The findings, published in Small, address one of the biggest challenges facing modern gene medicine—getting fragile therapeutic material to the right place inside cells.

“We are introducing salt-loaded lipid nanoparticles as a novel and broadly applicable design principle for gene delivery,” said Fanfei Meng, assistant professor and Presidential Frontier Faculty member in the Department of Pharmacological and Pharmaceutical Sciences. “What makes this exciting is that we can significantly improve delivery efficiency without needing to invent entirely new materials.”

Lipid nanoparticles, or LNPs, are tiny fat-based delivery vehicles widely used to transport fragile genetic material into cells. They became widely recognized during the COVID-19 pandemic through mRNA vaccines developed by Moderna and Pfizer. Today, scientists are also using LNPs to develop new treatments for cancer, rare diseases and genetic disorders.

Many cancers originate from a single cancer cell and evolve through early bursts of chromosome changes

A comprehensive multi-cancer study by researchers at The University of Texas MD Anderson Cancer Center has revealed that cancer cells within tumors are genetically diverse, yet all carry the same core genetic changes that can be traced back to a common ancestral cell, providing a single-cell view of how tumors adapt, survive and diversify. Understanding this helps explain why some cancer cells manage to survive treatment, paving the way for more tailored diagnostic and therapeutic strategies.

The study, published in Cancer Discovery, was led by Nicholas Navin, Ph.D., chair of Systems Biology. The research shows that cancer cells do not evolve slowly over time, but rather grow through sudden bursts of rapid genetic changes that include copy number alterations (CNAs)—gains or losses of entire sections of DNA. This creates a family tree of distinct new subpopulations that can influence tumor aggressiveness, metastasis and treatment response.

“Our findings provide the clearest views to date of how cancers originate and evolve at the single-cell level,” Navin said. “By revealing both the shared early genetic events and the bursts that drive ongoing diversity, we now have a roadmap for developing smarter clinical diagnostic and treatment strategies to improve patient outcomes.”

Scientists Just Found A Quantum Computer Hiding Inside You

FREE GUIDE: 📘 The Content Creator’s AI Blueprint – https://FirstMovers.ai/blueprint/

For 100 years the rule was absolute: to see quantum behavior, you freeze your machine to near absolute zero. In August 2025, a team at the University of Chicago broke it inside a living cell.

They turned enhanced yellow fluorescent protein from the same family that makes jellyfish glow into a working qubit, and detected the signal inside living mammalian cells and bacteria. Published in *Nature*, named a top-ten breakthrough of the year.

What you’ll learn:
✅ How a glowing protein became a real qubit.
✅ Why nature solved this before our best labs did.
✅ What genetically encoded quantum sensors mean by 2030.

There’s quantum machinery glowing inside you right now — and it’s more elegant than anything we’ve engineered.

#QuantumPhysics #Consciousness #Science.

Continue reading “Scientists Just Found A Quantum Computer Hiding Inside You” | >

Reliable Detection of SGLT2 Protein by Knockout-Based Antibody Characterization

BACKGROUND: SGLT2 (sodium-glucose cotransporter 2) mediates renal glucose reabsorption, and its pharmacological inhibition exerts cardio-and renoprotective benefits. Despite widespread clinical interest, reliable detection of SGLT2 protein remains challenging due to concerns regarding antibody specificity. METHODS: Eight commercially available anti-SGLT2 antibodies were evaluated by immunohistochemistry and Western blotting using kidneys and hearts from genetically engineered Sglt2-deficient mice and rats. Human kidney tissues, including renal cell carcinoma samples, were also examined. RESULTS: Among the antibodies tested, ab306558 and HPA041603 showed specific immunostaining in rodent kidneys, with minimal background in wild-type tissues and complete absence of staining in Sglt2-deficient samples. However, ab306558 was unsuitable for human samples because of nonspecific staining.

Brain circuit needed to incorporate new information may be linked to schizophrenia

One of the symptoms of schizophrenia is difficulty incorporating new information about the world. This can lead people with schizophrenia to struggle with making decisions and, eventually, to lose touch with reality.

MIT neuroscientists have now identified a gene mutation that appears to give rise to this type of difficulty. In a study of mice, the researchers found that the mutated gene impairs the function of a brain circuit that is responsible for updating beliefs based on new input.

This mutation, in a gene called grin2a, was originally identified in a large-scale screen of patients with schizophrenia. The new study suggests that drugs targeting this brain circuit could help with some of the cognitive impairments seen in people with schizophrenia.

World-first: therapy to make cells young again trialled in a person

Boston-based biotechnology company Life Biosciences has launched the first-in-human clinical trials of a pioneering “partial cellular reprogramming” technique designed to treat optic nerve damage caused by glaucoma and NAION. Based on previous genetic research, the therapy utilizes a modified virus to deliver three youth-restoring genes to retinal cells, aiming to reverse cellular aging while preserving their specialized functions. Addressing the critical risk of inducing cancer through uncontrolled cell division, the protocol incorporates a vital safety switch: the rejuvenating genes are only activated in the presence of the antibiotic doxycycline. The eye was strategically selected for these initial trials because its relative isolation minimizes the risk of systemic, life-threatening side effects. Involving up to 12 patients, this groundbreaking study serves as a crucial test not only for the potential restoration of vision but for the safety, viability, and future reputation of partial reprogramming as a broader anti-aging and regenerative medicine therapy.

A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged cells in the eye.

Long-read DNA test lifts rare disease diagnoses and could replace 15 other tests

A new test provides a much more complete picture of DNA than current standard diagnostics and leads to a diagnosis more often. The test can replace 15 other tests, making it faster and more efficient. Researchers from Radboud university medical center recommend in the New England Journal of Medicine that this test be adopted everywhere as the first choice for rare genetic disorders.

A condition is considered rare if it affects fewer than 1 in 2000 people. Nevertheless, up to 400 million people worldwide have a rare disease, as there are more than 7,000 different types. Eighty percent of these have a genetic cause. A diagnosis often takes years to obtain. Yet a diagnosis is important: It provides clarity, insight into the future, contact with others in similar situations, and the possibility to assess risks when planning to have children.

Researchers from Radboudumc and Maastricht UMC+ are working together to increase the chances of diagnosing genetic disorders. They compared current standard diagnostics—often involving multiple tests to reach a diagnosis—with a new DNA test in 1000 patients.

Sleep and exercise may curb heart risk from mutant white blood cells

Healthy sleep and regular exercise can work to counteract genetic mutations in white blood cells that are associated with cardiovascular disease and are most common among older people, Mount Sinai researchers have found. In a study published in Nature, the team reported for the first time that sufficient sleep and exercise can help reduce the cancer-like cell expansion and atherosclerotic risk linked to mutations that spontaneously occur in white blood cells.

These mutations accumulate over our lifetimes and occur most often in hematopoietic stem cells, which are the cells in bone marrow that make blood cells, including macrophages and monocytes, immune cells that help defend the body. When these cells develop mutations, they start to proliferate, multiplying faster than they should, and become more inflammatory, irritating or damaging tissues in the body.

This condition, known as clonal hematopoiesis (CH), is detectable in a quarter of people over age 70 and half of people over 80, the researchers say, though it is infrequent in young, healthy people.

The Intelligence of Our Cells with Michael Levin

Each one of us have made the remarkable journey from matter to mind. The destination is our existence, one whole conscious being. The marvellous nature of our intelligence can be traced to the aptitude of every individual cell in our body. The whole is greater than the sum of its parts. What if we could rewire the code that separates self from world? Tadpoles with eyes growing from their tails, worms with two heads-is the manifestation of biology governed entirely by chance?

Michael Levin is an American developmental and synthetic biologist at Tufts University, where he is the Vannevar Bush Distinguished Professor. Levin is a director of the Allen Discovery Center at Tufts University and Tufts Center for Regenerative and Developmental Biology. He is also co-director of the Institute for Computationally Designed Organisms with Josh Bongard.

00:00 — Collective Intelligence 03:38 — Cognitive Light Cones 09:32 — Scaling of the light cone 12:07-Definition of Intelligent Life 13:53 — Free Energy Principle 15:02 — Cognitive Glue 17:56 — Bioelectricity vs Genetics 23:23 — Limb Regeneration in Humans 24:24 — Solving Cancer 28:02 — Length of Effects 29:09 — Alien Life 31:31 — Communicating with our body organs 35:13 — Tic Tac Toe with an Alien 38:41 — Training our body organs 40:06 — Non-Cellular intelligence 41:03 — Is everything intelligent in the universe? 45:11 — Collective vs Parts 47:10 — Mike’s message to extraterrestrials.

/* */